title: Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy.
authors.affiliation: 1 Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan ; 3 Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Takahashi
authors.affiliation: 1 Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan ; 3 Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Takashi
authors.initials: T
authors.lastname: Eguchi
authors.affiliation: 1 Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan ; 3 Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Sarina
authors.initials: S
authors.lastname: Bains
authors.affiliation: 1 Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan ; 3 Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Prasad S
authors.initials: PS
authors.lastname: Adusumilli